Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Dec 29;21(1):125–135.e8. doi: 10.1016/j.cgh.2021.12.038

Figure 2.

Figure 2.

Modeled means (95% CI) of HBV DNA, HBV RNA, HBcrAg, qHBeAg and qHBsAg by time point, stratified by HBeAg status throughout follow-up

A. HBeAg positive

B. HBeAg positive to negative during follow-up

C. HBeAg negative

There was a significant decrease in HBV DNA, HBV RNA, HBcrAg, qHBeAg and qHBsAg among HBeAg positive (panel A) and HBeAg positive to negative (panel B) participants (P for all<.05). Among HBeAg negative participants, there was a significant decrease over time in HBV DNA (P=.03) and qHBsAg (P<.001), but not HBV RNA (P=.49) or HBcrAg (P=.63).